2024 annual financial data
Vistagen Therapeutics 2024 Operating margin
Vistagen Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -3,103.48%.
Operating income was -33,021,000 USD and net income was -29,362,000 USD.
Operating cash flow was -25,813,000 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,064,000 USD
- Operating income
- -33,021,000 USD
- Net income
- -29,362,000 USD
- Operating cash flow
- -25,813,000 USD